Loading...
XSHE
300653
Market cap545mUSD
Dec 05, Last price  
21.72CNY
1D
-0.41%
1Q
6.63%
IPO
163.17%
Name

Yantai Zhenghai Bio-Tech Co Ltd

Chart & Performance

D1W1MN
XSHE:300653 chart
P/E
28.65
P/S
10.62
EPS
0.76
Div Yield, %
3.69%
Shrs. gr., 5y
-0.16%
Rev. gr., 5y
5.36%
Revenues
363m
-12.19%
59,296,05777,376,968105,304,734128,132,520150,622,517182,782,114215,543,620279,807,036293,281,582400,175,251433,224,730413,652,710363,225,351
Net income
135m
-29.49%
8,515,11815,767,28933,660,49042,492,17845,470,11161,669,55485,815,067107,386,387118,333,984168,552,584185,436,805190,957,573134,639,109
CFO
151m
-16.12%
034,383,49430,791,51245,739,64249,249,89765,473,42077,466,025103,477,376118,432,079166,134,014187,838,040180,477,811151,383,955
Dividend
Jun 14, 20240.8018 CNY/sh

Notes

No notes on this company yet
Write a private note on this company, for your eyes only

Profile

Yantai Zhenghai Biotechnology Co., Ltd. engages in the research and development, production, and marketing of regenerative medical materials in China. It offers bone repair material, a partially deproteinised bone prepared from cancellous bones of calves after a series of treatment, such as decellularization and degreasing; oral cavity repair membrane line of products, which are used to treat defects of shallow oral cavity's soft tissue; and bio-membrane line of products that are used in neurosurgery to repair cerebral dura mater defect under the Heal-All brand name. The company also provides skin repair membrane line of products to repair wounds in dermal layer under the Heal-Full brand name. Yantai Zhenghai Biotechnology Co., Ltd. was founded in 2003 and is based in Yantai, China.
IPO date
May 16, 2017
Employees
Domiciled in
CN
Incorporated in
CN

Valuation

Title
CNY in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2024‑122023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑122015‑12
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT